HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Tuesday, 24 September 2013

Recents CEAs

Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers.  31 papers were listed this time. Here's a few in our areas of research interest:

Kularatna S, Whitty JA, Johnson NW, et al. Health state valuation in low- and middle-income countries: a systematic review of the literature. Value Health. 2013 Sep-Oct;16(6):1091-9. Epub 2013 Jul 16. PubMed PMID: 24041360.

Chhatwal J, Ferrante SA, Brass C, et al. Cost-effectiveness of boceprevir in patients previously treated for chronic hepatitis C genotype 1 infection in the United States. Value Health. 2013 Sep-Oct;16(6):973-86. PubMed PMID: 24041347.

Naylor RN, John PM, Winn AN, et al. The Cost-Effectiveness of Maturity-Onset Diabetes of the Young Genetic  Testing - Translating Genomic Advances into Practical Health Applications. Diabetes Care. 2013 Sep 11. [Epub ahead of print] PubMed PMID: 24026547.

Blázquez-Pérez A, San Miguel R, Mar J. Cost-Effectiveness Analysis of Triple Therapy with Protease Inhibitors in Treatment-Naive Hepatitis C Patients. Pharmacoeconomics. 2013 Sep 3. [Epub ahead of print] PubMed PMID: 24000086.